Provoking change, Promoting better care
Quality care, safe care, collaboration for health
Michael L. Millenson, president of Health Quality Advisors LLC, is an activist, consultant, researcher and writer who is internationally recognized as a leader in promoting the use of information to make care better, safer and more patient-centered.
The author of the critically acclaimed book, Demanding Medical Excellence: Doctors and Accountability in the Information Age, Michael has testified before Congress, lectured at the Harvard Business School and consulted on strategy to a broad range of organizations. He has keynoted professional meetings worldwide, and his work has been cited by media outlets such as The New York Times, Washington Post and National Public Radio, along with academic and policy journals. He also writes a regular column for Forbes.com.
“Millenson is in the vanguard of the movement” to measure and improve the quality of health care.
—National Public Radio
Read about Demanding Medical Excellence, available at Amazon and B&N
“You weave the past, present and future towards safe care.”
—Vonda Vaden Bates, Healthcare Safety Advocate
“Your intellectual thought leadership efforts have helped to galvanize the more innovative health care systems across the United States to make care safer.”
—David Joseph Ballard, MD, MSPH, PhD, MBA
“The origins of the quality revolution reside in dramatic events and ideas [such as] Michael Millenson’s call to action in Demanding Medical Excellence.”
—Pittsburgh Regional Healthcare Initiative
“My brilliant colleague Michael Millenson is my ‘guru’ on evidence-based medicine.”
—Tom Peters, author, In Search of Excellence
“Highly regarded in the area of quality of care.”
—George M. Lundberg MD, former editor, JAMA
“An incredible advocate on behalf of patients everywhere.”
—Shantanu Nundy, MD, chief medical officer, Accolade
and author, Care After Covid
“Michael is one of the first individuals to call for transforming U.S. health care along market principles related to value purchasing, evidence-based medicine, patient safety and transparency.”
—Timothy J. Muris, chairman, Federal Trade Commission